deltatrials
Completed PHASE2 INTERVENTIONAL NCT00001637

Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults

Low Intensity Preparative Regimen Followed by HLA-Matched, Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematologic Malignancies in Older Adults

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Chronic Lymphocytic Leukemia Graft vs Host Disease Leukemia Myelodysplastic Syndrome Myeloid Leukemia
Interventions Blood cell transplantation
Updated 24 times since 2017 Last updated: Dec 14, 2019 Started: Sep 29, 1997 Primary completion: Jul 28, 2008 Completion: Dec 28, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00001637, this PHASE2 trial focuses on Chronic Lymphocytic Leukemia and Graft vs Host Disease and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 24 times since 1997, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Sep 2019 · 31 days · monthly snapshot~Sep 2019 – ~Oct 2019 · 30 days · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Dec 2019 · 30 days · monthly snapshot~Dec 2019 – ~Jan 2020 · 31 days · monthly snapshot~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

24 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2020 — Jan 2021 [monthly]

    Completed PHASE2

  5. Dec 2019 — Jan 2020 [monthly]

    Completed PHASE2

▶ Show 19 earlier versions

  1. Nov 2019 — Dec 2019 [monthly]

    Completed PHASE2

  2. Oct 2019 — Nov 2019 [monthly]

    Completed PHASE2

  3. Sep 2019 — Oct 2019 [monthly]

    Completed PHASE2

  4. Aug 2019 — Sep 2019 [monthly]

    Completed PHASE2

  5. Jul 2019 — Aug 2019 [monthly]

    Completed PHASE2

  6. Jun 2019 — Jul 2019 [monthly]

    Completed PHASE2

  7. May 2019 — Jun 2019 [monthly]

    Completed PHASE2

  8. Apr 2019 — May 2019 [monthly]

    Completed PHASE2

  9. Mar 2019 — Apr 2019 [monthly]

    Completed PHASE2

  10. Feb 2019 — Mar 2019 [monthly]

    Completed PHASE2

  11. Jan 2019 — Feb 2019 [monthly]

    Completed PHASE2

  12. Dec 2018 — Jan 2019 [monthly]

    Completed PHASE2

  13. Nov 2018 — Dec 2018 [monthly]

    Completed PHASE2

  14. Oct 2018 — Nov 2018 [monthly]

    Completed PHASE2

  15. Sep 2018 — Oct 2018 [monthly]

    Completed PHASE2

  16. Aug 2018 — Sep 2018 [monthly]

    Completed PHASE2

  17. Jul 2018 — Aug 2018 [monthly]

    Completed PHASE2

  18. Jun 2018 — Jul 2018 [monthly]

    Completed PHASE2

  19. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Sep 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations